Grifols S.A. ADR (GRFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GRFS | CNTA | STVN | ||
| Company | Grifols S.A. ADR | Centessa Pharmaceuticals Plc ADR | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 8.08 | 39.55 | 16.51 | ||
| High | 8.30 | 39.55 | 17.12 | ||
| Low | 8.08 | 39.35 | 16.43 | ||
| Latest | 8.24 | 39.42 | 17.00 | ||
| Change | +0.33 | -0.03 | +0.74 | ||
| % Change | +4.17% | -0.08% | +4.55% | ||
| Volume | 432,800 | 3,031,300 | 356,200 | ||
| 20-Day Average Volume | 757,970 | 2,642,745 | 598,835 | ||
| Previous Close | 7.91 | 39.45 | 16.26 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.29 | 39.54 | 15.05 | ||
| 20-Day Raw Stochastic | 39.18% | 39.39% | 92.80% | ||
| 20-Day Relative Strength | 49.03 | 71.76 | 63.64 | ||
| Weighted Alpha | +1.38 | +115.00 | -24.50 | ||
| Today's Opinion | 96% Sell | 88% Buy | 40% Sell | ||
| Previous Opinion | 96% Sell | 88% Buy | 56% Sell | ||
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.13% since 04/23/26 | -0.03% since 04/23/26 | +4.68% since 04/23/26 | ||
| Low | 7.87 on 04/29/26 | 39.35 on 04/30/26 | 15.60 on 04/24/26 | ||
| High | 8.30 on 04/30/26 | 39.55 on 04/30/26 | 17.12 on 04/30/26 | ||
| 1-Month | |||||
| %Chg | +8.99% since 03/30/26 | +42.93% since 03/30/26 | +26.21% since 03/30/26 | ||
| Low | 7.73 on 03/31/26 | 39.16 on 04/13/26 | 13.39 on 04/10/26 | ||
| High | 8.83 on 04/17/26 | 40.26 on 03/31/26 | 17.28 on 04/23/26 | ||
| 3-Month | |||||
| %Chg | -10.92% since 01/30/26 | +60.44% since 01/30/26 | +9.11% since 01/30/26 | ||
| Low | 7.39 on 03/25/26 | 22.50 on 02/11/26 | 12.89 on 03/27/26 | ||
| High | 9.77 on 02/18/26 | 40.26 on 03/31/26 | 17.59 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | -10.04% since 10/30/25 | +62.02% since 10/30/25 | -31.84% since 10/30/25 | ||
| Low | 7.39 on 03/25/26 | 17.05 on 11/05/25 | 12.89 on 03/27/26 | ||
| High | 9.90 on 11/04/25 | 40.26 on 03/31/26 | 27.00 on 11/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,607,938 | 5,882,568 | 5,148,331 | ||
| Shares Outstanding, K | 680,575 | 149,228 | 302,843 | ||
| Annual Sales | 8,512,650,000 | 15,000,000 | 1,342,160,000 | ||
| Annual Net Income | 454,820,000 | -197,530,000 | 158,210,000 | ||
| Last Quarter Sales | 2,304,030,000 | 0 | 399,570,000 | ||
| Last Quarter Net Income | 110,600,000 | -66,160,000 | 54,410,000 | ||
| 60-Month Beta | 0.70 | 1.25 | 0.62 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.19 on 07/28/25 | -0.48 on 03/31/26 | 0.21 on 03/04/26 | ||
| Earnings Date | 02/25/26 | 05/13/26 | 05/07/26 | ||
| Most Recent Dividend | 0.142 on 08/12/25 | N/A | N/A | ||
| Next Ex-Dividends Date | 08/12/25 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 27.10 | ||